Your session is about to expire
Stereotactic: What You Need To Know
Stereotactic Radiosurgery: Overview and Technology Used
Stereotactic radiosurgery (SRS) is a non-surgical radiation therapy capable of delivering precise, high-dose radiation to brain tumors and other targeted areas in the brain. Despite the implication of invasiveness suggested by the term "surgery," SRS is characterized by its non-invasive approach, requiring no cutting or incision.
The technology underpinning SRS is advanced, utilizing medical imaging techniques such as MRI or CT scans to guide the radiation delivery with accuracy and precision. This approach targets tumor cells while sparing the surrounding healthy tissue. The tools employed in this technique include:
- linear accelerators (LINACs)
- Gamma Knife machines
- CyberKnife systems, among others.
A LINAC machine produces high-energy x-rays for treatment and is widely used in various radiotherapy procedures. The Gamma Knife, contrary to what its name might suggest, is a device that delivers 192 beams of gamma radiation simultaneously to a single focus point within the skull. The CyberKnife system incorporates robotics and real-time imaging to achieve highly accurate SRS treatments.
Each tool has its unique set of advantages and limitations, which may vary depending on the specifics of a given case.
Procedure and Applications of Stereotactic Radiosurgery
Stereotactic radiosurgery (SRS) is a non-surgical procedure that utilizes highly focused radiation beams to treat small, well-defined areas of the brain. To ensure precision during treatment, a head frame may be used to fix the patient's position. MRI or CT scans assist in pinpointing the exact location for treatment.
The applications of SRS encompass a range of conditions. It is effectively used in the treatment of:
- Brain tumors
- Arteriovenous malformations
Additionally, neurological conditions such as Trigeminal neuralgia have shown positive responses to SRS. The absence of incisions reduces the risk and recovery time compared to traditional surgery.
SRS is not limited to treating brain-related issues. Lung cancer, liver cancer, and other types of body cancers can also be treated using stereotactic body radiotherapy (SBRT), which applies a similar approach to areas outside the brain.
Clinical trials continue to explore the potential of these treatments, offering insights into additional applications and effectiveness for various conditions.
Potential Risks, Complications, and Preparation Before the Procedure
Understanding potential risks is crucial in clinical trials, which often involve new treatments. These treatments can lead to unknown side effects, ranging from minor issues like headaches or fatigue to major complications that could affect long-term health.
Complications are a possibility as well. The condition of a participant might not improve after the trial, and in some cases, it could even worsen. Additionally, the trial medication might interact with other drugs the participant is taking.
Preparation before participating in a clinical trial is key. It involves understanding the process and making any necessary lifestyle changes during the trial period. Instructions on how to prepare, including dietary restrictions and medication adjustments, are provided to ensure readiness for the trial.
In summary:
- Risks involve possible unknown side effects from new treatments.
- Complications include the potential for the condition to not improve or to worsen, along with possible drug interactions.
- Preparation entails understanding the trial process and adhering to instructions for diet and medication changes.
Participation in a clinical trial is voluntary, and all factors should be considered.
During and After the Stereotactic Procedure: Expectations and Results
During the stereotactic procedure, patients remain awake. The head is held steady in a special frame, and little pain is felt. Imaging scans are used by doctors to guide the procedure, targeting specific areas of the brain.
Following the procedure, some mild discomfort may be reported, including headaches or nausea. These symptoms are typically temporary and can be managed with medication.
The results of the stereotactic procedure vary depending on the patient's condition before the procedure and the aim of the treatment, whether it be Parkinson's disease, epilepsy, tumors, or other conditions affecting the brain.
Regular follow-ups may include:
- MRI scans
- Neurological evaluations
to monitor progress and assess the effectiveness of the treatment.